The Latest Breaking News from SNPs

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 15.1% on an annualized basis producing an average annual return of 25.9%. Currently, Synopsys has a market capitalization of $46.08 billion.

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 5 years by 22.62% on an annualized basis producing an average annual return of 31.23%. Currently, Synopsys has a market capitalization of $44.42 billion.

Investors' concerns over the Federal Reserve's interest rate increases to combat inflationary pressures, and looming recession fears, have heightened market volatility. However, a few companies look sufficiently well positioned to withstand the current market turbulence and they recently raised their full-year outlooks. Therefore, we think it could be wise to…

Thanks to strategic partnerships and acquisitions, technology company Synopsys (SNPS) has achieved considerable operating-margin expansion across its business sectors. And given the company’s strong fundamentals and potential for long-term profitable growth, we think its stock is a great bet now. Read on.

Synopsys, Inc. (NASDAQ: SNPS) reported secon

Synopsys, a maker of semiconductor design software, surged Thursday after it handily beat analyst estimates for its fiscal second quarter.

Despite aggressive interest rate hikes expectations and other factors keeping the market volatile, the recovering labor market and substantial corporate profits have driven the performance of some quality growth stocks like Synopsys (SNPS) and Adobe (ADBE). But which of these two stocks is a better buy now? Read more to…

Despite no clarity on when the Russia-Ukraine war will end, surging inflation, and logistical hindrances, the U.S. economy looks sufficiently resilient to weather the crises. Given this backdrop, we think shares of beaten-down growth stocks IQVIA (IQV), West Pharmaceutical (WST), and Synopsys (SNPS) could soar in price in the coming…